AGENTS FOR THE TREATMENT OF HEART-FAILURE

[91] INVITRO ACTIVITY OF RO363, A BETA1-ADRENOCEPTOR SELECTIVE AGONIST [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1980, 68 (04) : 677 - 685

[92] ISHIZAKI H, 1979, J BIOL CHEM, V254, P9651

[93] INOTROPIC EFFECTS OF UK 14,275, A PHOSPHODIESTERASE INHIBITOR, IN MAAN [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 5 (01) : 7 - 11

[94] SOME ASPECTS OF CARDIOVASCULAR PHARMACOLOGY OF UK 14,275 IN PATIENTS WITH CORONARY-ARTERY DISEASE [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 5 (01) : 13 - 18

[95] BENEFICIAL EFFECT OF AMRINONE ON MYOCARDIAL OXYGEN-CONSUMPTION DURING ACUTE LEFT-VENTRICULAR FAILURE IN DOGS [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1981, 48 (01) : 75 - 83

[96] BIOCHEMICAL-STUDIES ON THE MECHANISM OF CARDIOTONIC ACTIVITY OF MDL-17,043 [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 (03) : 509 - 514

[97] KATZ AM, 1979, ADV CYCLIC NUCLEOTID, V2, P304

[98] IN KITTEN VENTRICULAR MYOCARDIUM, THE INOTROPIC POTENCY OF AN AGONIST IS DETERMINED BY BOTH ITS INTRINSIC ACTIVITY FOR THE ADENYLYL CYCLASE AND ITS AFFINITY FOR THE BETA-ADRENOCEPTORS [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1981, 317 (01) : 13 - 18

[99] KENAKIN TP, 1981, J PHARMACOL EXP THER, V216, P210

[100] KIM RSS, 1981, PHARMACOL THERAPEUT, V14, P391

[91] INVITRO ACTIVITY OF RO363, A BETA1-ADRENOCEPTOR SELECTIVE AGONIST [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1980, 68 (04) : 677 - 685

[92] ISHIZAKI H, 1979, J BIOL CHEM, V254, P9651

[93] INOTROPIC EFFECTS OF UK 14,275, A PHOSPHODIESTERASE INHIBITOR, IN MAAN [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 5 (01) : 7 - 11

[94] SOME ASPECTS OF CARDIOVASCULAR PHARMACOLOGY OF UK 14,275 IN PATIENTS WITH CORONARY-ARTERY DISEASE [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 5 (01) : 13 - 18

[95] BENEFICIAL EFFECT OF AMRINONE ON MYOCARDIAL OXYGEN-CONSUMPTION DURING ACUTE LEFT-VENTRICULAR FAILURE IN DOGS [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1981, 48 (01) : 75 - 83

[96] BIOCHEMICAL-STUDIES ON THE MECHANISM OF CARDIOTONIC ACTIVITY OF MDL-17,043 [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 (03) : 509 - 514

[97] KATZ AM, 1979, ADV CYCLIC NUCLEOTID, V2, P304

[98] IN KITTEN VENTRICULAR MYOCARDIUM, THE INOTROPIC POTENCY OF AN AGONIST IS DETERMINED BY BOTH ITS INTRINSIC ACTIVITY FOR THE ADENYLYL CYCLASE AND ITS AFFINITY FOR THE BETA-ADRENOCEPTORS [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1981, 317 (01) : 13 - 18

[99] KENAKIN TP, 1981, J PHARMACOL EXP THER, V216, P210

[100] KIM RSS, 1981, PHARMACOL THERAPEUT, V14, P391